LIFE AI Announcement
The Intelligence Layer of Human Health - Avalanche’s flagship L1 for Healthcare AI.Twitter: https://twitter.com/LifeNetwork_AIGroup:@lifenetwork_group
What our data says
- Created between September 2023 and May 2024.
- Of the channels created in the same period, 98% are smaller than this one.
- Larger than 81% of English-language AI channels.
- Publishes daily, more often than 80% of English-language AI channels.
- A typical post is seen by 2% of subscribers — less than in 79% of English-language channels of similar size.
This channel is part of the discussion
LIFE AI Announcement appears in 58 event pages on TGScopeThe next edge in drug development will come from understanding patients at higher resolution. For decades, clinical evidence was shaped by scheduled visits. What patients reported. What clinicians observed. Everything between visits remained largely unseen. The FDA’s Digital…
A healthcare AI program requires more than a model. Translating a concept into clinical deployment demands specialized expertise across the full development lifecycle: → Domain experts to define the clinical problem → Clinical investigators to establish validity and safety →…
Today in Singapore, we took a question we have been working on at Life AI to a much bigger room. As AI accelerates drug discovery, how do we build the operating infrastructure to move what we discover through clinical validation, evidence, and real-world execution? Our…
Life AI Named a Top 20 Finalist in the NVIDIA Inception Grand Challenge 2026 Life AI has been named one of the Top 20 Finalists in the NVIDIA Inception Grand Challenge 2026, selected from more than 500 startups across Asia Pacific. The recognition follows Life AI’s selection in…
The next edge in drug development will come from understanding patients at higher resolution. For decades, clinical evidence was shaped by scheduled visits. What patients reported. What clinicians observed. Everything between visits remained largely unseen. The FDA’s Digital…
The next edge in drug development will come from understanding patients at higher resolution. For decades, clinical evidence was shaped by scheduled visits. What patients reported. What clinicians observed. Everything between visits remained largely unseen. The FDA’s Digital…